ACR appropriateness criteria: Permanent source brachytherapy for prostate cancer-Reference-Cited by-同舟云学术

ACR appropriateness criteria: Permanent source brachytherapy for prostate cancer

Published:2017-03 Issue:2 Volume:16 Page:266-276
ISSN:1538-4721
Container-title:Brachytherapy
language:en
Short-container-title:Brachytherapy

Author:

Davis Brian J.,Taira Al V.,Nguyen Paul L.,Assimos Dean G.,D'Amico Anthony V.,Gottschalk Alexander R.,Gustafson Gary S.,Keole Sameer R.,Liauw Stanley L.,Lloyd Shane,McLaughlin Patrick W.,Movsas Benjamin,Prestidge Bradley R.,Showalter Timothy N.,Vapiwala Neha

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference91 articles.

1. The NCCN Clinical Practice Guidelines in Oncology™ Prostate Cancer V.1.2015 ©,2015

2. Population-based 10-year oncologic outcomes after low-dose-rate brachytherapy for low-risk and intermediate-risk prostate cancer;Morris;Cancer,2013

3. Fifteen-year biochemical relapse-free survival, cause-specific survival, and overall survival following I(125) prostate brachytherapy in clinically localized prostate cancer: Seattle experience;Sylvester;Int J Radiat Oncol Biol Phys,2011

4. Long-term outcome for clinically localized prostate cancer treated with permanent interstitial brachytherapy;Taira;Int J Radiat Oncol Biol Phys,2011

5. Comparison of tumor control and toxicity outcomes of high-dose intensity-modulated radiotherapy and brachytherapy for patients with favorable risk prostate cancer;Zelefsky;Urology,2011

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toward a deep learning-based magnetic resonance imaging only workflow for postimplant dosimetry in I-125 seed brachytherapy for prostate cancer;Brachytherapy;2024-01

2. Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation Therapy: Brachytherapy as Dose Escalation for Localized Prostate Cancer;International Journal of Radiation Oncology*Biology*Physics;2023-04

3. Permanent LDR prostate brachytherapy: Comprehensive characterization of seed-dynamics within the prostate on a seed-only level;Brachytherapy;2022-09

4. ACR-ABS-ASTRO Practice Parameter for Transperineal Permanent Brachytherapy of Prostate Cancer;American Journal of Clinical Oncology;2022-05-06

5. Recent results of HDR brachytherapy in the treatment of localized forms of prostate cancer;Український радіологічний та онкологічний журнал;2022-03-29